Nachrichten zur Madrigal Pharmaceuticals Corp. Aktie

Madrigal Pharmaceuticals: Rezdiffras US And EU Rollout Remains Promising

…

Madrigal Pharmaceuticals - Steigende Absätze bei Rezdiffra sorgen für Schwung!

Geschäftstreiber: Madrigal Pharmaceuticals ist ein US-Biopharmaunternehmen, das sich auf Therapien zur Behandlung von MASH spezialisiert. Mit Rezdiffra (Resmetirom) verfügt man…

Madrigal Pharmaceuticals: Rezdiffra Expansion Avenues Shift Focus To Long Term

…

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…

Why Madrigal Pharmaceuticals Stock Is Soaring Today

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain…

Madrigal Pharmaceuticals Aktie: Blockbuster-Potenzial und frische Übernahmespekulationen

Kulmbach (www.aktiencheck.de) - Madrigal Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Madrigal…

Madrigal Pharmaceuticals Rezdiffra Vies For Blockbuster Status In MASH

…

Why Madrigal Pharmaceuticals Stock Was Plummeting This Week

An estimates-beating set of preliminary financial numbers and two bullish analyst updates werent enough to lift Madrigal Pharmaceuticals (NASDAQ: MDGL)…

Why Madrigal Pharmaceuticals Stock Is Sinking Today

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came…

Madrigal Pharmaceuticals director Fred Craves sells shares worth $1.14 million By Investing.com

Madrigal Pharmaceuticals director Fred Craves sells shares worth $1.14 million…

Arrowhead Pharma und Madrigal gehen steil: Zwischen Adipositas- und Übernahmefantasie

Die Biotechnologie-Branche bietet viele spannende Storys. Einen aussichtsreichen Aktienkorb mit 14 verschiedenen Titeln bildet der Biotech Supertrends Index ab. Zuletzt…

3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

When a companys shares shoot up 82% in 12 months, investors clearly think its a good time to be a…

Madrigal Pharmaceuticals gains amid takeover speculation

…

Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European Expansion

…

AKTIONÄR-Hot-Stock Madrigal Pharmaceuticals: Top-News – Aktie gewinnt 19 Prozent

Die Aktie des US-Biotech-Unternehmens Madrigal Pharmaceuticals kann am heutigen Handelstag einen satten Kurssprung hinlegen. Damit konnte nicht nur die jüngste…

AKTIONÄR-Hot-Stock Madrigal Pharmaceuticals: Top-News – Aktie gewinnt 19 Prozent

Die Aktie des US-Biotech-Unternehmens Madrigal Pharmaceuticals kann am heutigen Handelstag einen satten Kurssprung hinlegen. Damit konnte nicht nur die jüngste…

Madrigal Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation

…

Madrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 Earnings

…

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024

CONSHOHOCKEN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will…

Is Madrigal Pharmaceuticals Stock a Buy?

The biotech could be worth a lot more in 10 years.…

Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel

CONSHOHOCKEN, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering…

Is Madrigal Pharmaceuticals a Millionaire Maker?

Its revenue ramp-up is just starting, and its market looks lucrative.…

Is Madrigal Pharmaceuticals Stock a Buy?

The company could become a prominent player in the biotech industry, but that might take a while.…

Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Eli Lilly just drizzled on Madrigal Pharmaceuticals parade.…

Madrigal Pharmaceuticals senior VP sells $570,000 in stock By Investing.com

Madrigal Pharmaceuticals senior VP sells $570,000 in stock…

Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked

…

AKTIONÄR-Hot-Stock Madrigal Pharmaceuticals: Aktie mit Kurssprung – was ist da los?

Die Aktie des US-Biotech-Unternehmens Madrigal Pharmaceuticals entwickelt sich seit der Empfehlung des AKTIONÄR in der Rubrik „Hot-Stock der Woche“ in…

AKTIONÄR-Hot-Stock Madrigal Pharmaceuticals: Aktie mit Kurssprung – was ist da los?

Die Aktie des US-Biotech-Unternehmens Madrigal Pharmaceuticals entwickelt sich seit der Empfehlung des AKTIONÄR in der Rubrik „Hot-Stock der Woche“ in…

Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company…

Is Madrigal Pharmaceuticals Stock a Buy?

Its not the most prominent biotech, but it has an important claim to fame.…

Madrigal Pharmaceuticals (MDGL) Q1 2024 Earnings Call Transcript

…

US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Excitement grows as the FDAs first approval for MASH treatment nears commercialization, according to Spherix Global Insights. Excitement grows as…

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

These businesses should see good times ahead.…

Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

Both stocks are pretty risky, but one of them more so than the other.…

Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval? @themotleyfool #stocks $MDGL

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?…

Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?…

Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

Drugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI…

Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?

Madrigal has one key advantage over its two huge potential future rivals.…

Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win? @themotleyfool #stocks $MDGL $NVO $LLY

Madrigal has one key advantage over its two huge potential future rivals.…

Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis

CONSHOHOCKEN, Pa., March 14, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering…

dpa-AFX ProFeed